Clin2
NCT06916702Possibly a fitSuspended

Safety study of BI 3031185 in healthy volunteers

Healthy

Treatments studied

This trial tests how well different doses of BI 3031185 are tolerated by healthy adults. It helps researchers understand the safety of this new medicine.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
100 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You must be a healthy adult, either male or female (women must be unable to become pregnant).
  • Your age must be between 18 and 55, depending on the part of the study.
  • Your body mass index (BMI) must be between 20 and 29.9, and you must weigh at least 132 pounds (60 kg).
  • You must have normal blood pressure, heart rate, and lab test results.
  • You must sign a consent form agreeing to participate.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06745297Recruiting· Phase 1
Testing a new medicine in healthy men for safety

This study tests a new medicine (BI 3776528) in healthy men to see how well different doses are tolerated. It helps researchers find the safest dose before testing in people with a condition.

Berlin
NCT07486115Recruiting· Phase 1
Testing safety of BI 3814916 in healthy volunteers

This trial tests how safe and tolerable different doses of the study drug BI 3814916 are in healthy adults. It helps find the right dose for future studies.

Edegem
NCT07765498Not yet recruiting· Phase 1
Safety study of a new medicine in healthy volunteers

This trial tests a new medicine, currently known by the code LY4355756, in healthy people to check its safety and how the body handles it. Your participation could help show if this medicine is safe enough to move into larger testing.

Dallas, Texas
NCT07708493Not yet recruiting· Phase 1
Study of a new medicine in healthy men with normal or overweight

This study tests how a new medicine (BI 3034701) moves through the body in healthy men who have normal weight or are overweight. It helps find the right dose and understand how the medicine works.

NCT07120425Recruiting· Phase 1
Testing IBI3032 in healthy volunteers

This study tests a new drug called IBI3032 in healthy volunteers to see how safe it is and how the body processes it. If you are in good health, you may be able to join.

Lenexa, Kansas
NCT07486102Recruiting· Phase 1
Study of BI 3000202 in people with and without liver problems

This study tests how a new medicine, BI 3000202, is absorbed into the blood. It includes people with different levels of liver function (normal, mild, moderate, or severe) to see if liver problems affect how the medicine works.

San Antonio, Texas

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.